TY - JOUR AU - Dohner, H. AU - Estey, E. H. AU - Amadori, S. AU - Appelbaum, F. R. AU - Buchner, T. AU - Burnett, A. K. AU - Dombret, H. AU - Fenaux, P. AU - Grimwade, D. AU - Larson, R. A. PY - 2010 DA - 2010// TI - Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-07-235358 DO - 10.1182/blood-2009-07-235358 ID - Dohner2010 ER - TY - JOUR AU - Fey, M. F. AU - Dreyling, M. PY - 2010 DA - 2010// TI - Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq179 DO - 10.1093/annonc/mdq179 ID - Fey2010 ER - TY - BOOK PY - 2013 DA - 2013// TI - NCCN Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia. v.2.2013 PB - National Comprehensive Cancer Network CY - Fort Washington, PA ID - ref3 ER - TY - STD TI - Dacogen [Summary of Product Characteristics]. 2013, London, United Kingdom: European Medicines Agency, Available at: [http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002221/human_med_001589.jsp&mid=WC0b01ac058001d124]. Accessed: 1-28-2014 UR - http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002221/human_med_001589.jsp&mid=WC0b01ac058001d124 ID - ref4 ER - TY - STD TI - Dacogen [package insert]. 2010, Woodcliff Lake, NJ: Eisai Inc ID - ref5 ER - TY - JOUR AU - Kantarjian, H. AU - Oki, Y. AU - Garcia-Manero, G. AU - Huang, X. AU - O'Brien, S. AU - Cortes, J. AU - Faderl, S. AU - Bueso-Ramos, C. AU - Ravandi, F. AU - Estrov, Z. PY - 2007 DA - 2007// TI - Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-05-021162 DO - 10.1182/blood-2006-05-021162 ID - Kantarjian2007 ER - TY - JOUR AU - Cashen, A. F. AU - Schiller, G. J. AU - O'Donnell, M. R. AU - Dipersio, J. F. PY - 2010 DA - 2010// TI - Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.23.9178 DO - 10.1200/JCO.2009.23.9178 ID - Cashen2010 ER - TY - JOUR AU - Kantarjian, H. M. AU - Thomas, X. G. AU - Dmoszynska, A. AU - Wierzbowska, A. AU - Mazur, G. AU - Mayer, J. AU - Gau, J. -. P. AU - Chou, W. -. C. AU - Buckstein, R. AU - Cermak, J. PY - 2012 DA - 2012// TI - Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.38.9429 DO - 10.1200/JCO.2011.38.9429 ID - Kantarjian2012 ER - TY - JOUR AU - Slovak, M. L. AU - Kopecky, K. J. AU - Cassileth, P. A. AU - Harrington, D. H. AU - Theil, K. S. AU - Mohamed, A. AU - Paietta, E. AU - Willman, C. L. AU - Head, D. R. AU - Rowe, J. M. PY - 2000 DA - 2000// TI - Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest oncology group/Eastern cooperative oncology group study JO - Blood VL - 96 ID - Slovak2000 ER - TY - JOUR AU - Bennett, J. M. AU - Young, M. L. AU - Andersen, J. W. AU - Cassileth, P. A. AU - Tallman, M. S. AU - Paietta, E. AU - Wiernik, P. H. AU - Rowe, J. M. PY - 1997 DA - 1997// TI - Long-term survival in acute myeloid leukemia: the Eastern cooperative oncology group experience JO - Cancer VL - 80 UR - https://doi.org/3.0.CO;2-G DO - 3.0.CO;2-G ID - Bennett1997 ER - TY - JOUR AU - Goldstone, A. H. AU - Burnett, A. K. AU - Wheatley, K. AU - Smith, A. G. AU - Hutchinson, R. M. AU - Clark, R. E. PY - 2001 DA - 2001// TI - Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial JO - Blood VL - 98 UR - https://doi.org/10.1182/blood.V98.5.1302 DO - 10.1182/blood.V98.5.1302 ID - Goldstone2001 ER - TY - JOUR AU - Appelbaum, F. R. AU - Gundacker, H. AU - Head, D. R. AU - Slovak, M. L. AU - Willman, C. L. AU - Godwin, J. E. AU - Anderson, J. E. AU - Petersdorf, S. H. PY - 2006 DA - 2006// TI - Age and acute myeloid leukemia JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-09-3724 DO - 10.1182/blood-2005-09-3724 ID - Appelbaum2006 ER - TY - JOUR AU - Kantarjian, H. AU - O'Brien, S. AU - Cortes, J. AU - Giles, F. AU - Faderl, S. AU - Jabbour, E. AU - Garcia-Manero, G. AU - Wierda, W. AU - Pierce, S. AU - Shan, J. PY - 2006 DA - 2006// TI - Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome JO - Cancer VL - 106 UR - https://doi.org/10.1002/cncr.21723 DO - 10.1002/cncr.21723 ID - Kantarjian2006 ER - TY - JOUR AU - Fenaux, P. AU - Mufti, G. J. AU - Hellstrom-Lindberg, E. AU - Santini, V. AU - Gattermann, N. AU - Germing, U. AU - Sanz, G. AU - List, A. F. AU - Gore, S. AU - Seymour, J. F. PY - 2010 DA - 2010// TI - Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.23.8329 DO - 10.1200/JCO.2009.23.8329 ID - Fenaux2010 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/14/69/prepub UR - http://www.biomedcentral.com/1471-2407/14/69/prepub ID - ref15 ER -